Long-term Survivorship and Outcomes of Patients Without Dysplasia Undergoing Capsular Repair During Primary Hip Arthroscopy for Femoroacetabular Impingement Syndrome
Authors: Domb BG, Lee MS, Owens JS, Harris WT
Journal: American Journal of Sports Medicine, July 2024
DOI: 10.1177/03635465241248603
Objective
To evaluate 10-year clinical outcomes and native hip joint survivorship after hip arthroscopy with capsular repair in patients with femoroacetabular impingement syndrome (FAIS) but without dysplasia.
Methodology
A follow-up study of 145 hips undergoing arthroscopic capsular repair, comparing outcomes and conversion to total hip arthroplasty against controls without capsular repair.
Key Findings
- 91% of patients maintained native hip joint function at 10 years.
- Significant long-term improvements in pain and hip function were observed.
- Capsular repair showed a trend toward reduced risk of subsequent hip replacement.
Conclusion
Capsular repair during hip arthroscopy for FAIS patients without dysplasia confers durable joint preservation and symptomatic benefit.
What Does This Mean for Providers?
- Capsular repair should be strongly considered during hip arthroscopy in FAIS patients without dysplasia to enhance joint stability and potentially delay or prevent arthroplasty.
- Long-term data support capsular repair as an effective technique to improve patient outcomes and survivorship.
- Incorporate capsular management strategies in surgical planning for FAIS patients to optimize durability of arthroscopic interventions.
